If everything is true regarding Russian trial, the March ending date must be for announcement of final results IMO. Actual dosing would be pretty much done by now along with the 29 day period of taking blood tests and analyzing how B/CV working in the dosed patients. Now the ongoing part of the trial may be simply amassing, correlating, and reporting the final data. Would seem this is at least a possibility with Russia just announcing a new "cure" for CV.
Fingers crossed, but have to admit this info looks pretty impressive.
(9)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links